New heart scan could spot hidden blockages without surgery

NCT ID NCT07439133

Recruiting now Diagnosis Sponsor: Sinotau Pharmaceutical Group Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This phase 3 trial tests whether an injection called XTR004, used with a PET scan, can accurately detect blood flow-blocking narrowings in heart arteries. About 395 adults with known or suspected stable coronary artery disease will receive the injection and undergo imaging. The results will be compared to standard angiography to see if this less invasive method is reliable.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: XTR004 (99mTechnetium Sestamibi)
What this could lead to: If successful, this could provide a more accurate, non-invasive way to detect dangerous artery blockages, potentially reducing the need for invasive procedures.
What could go wrong: This is a diagnostic trial, not a treatment. Even if accurate, it may not change patient outcomes. The test involves radiation exposure, and results depend on interpretation.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CORONARY ARTERY DISEASE (CAD) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

coronary artery disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

CORONARY ARTERY DISEASE (CAD)

Contacts and locations

Locations

Beijing Anzhen Hospital, Capital Medical University
RECRUITING

Beijing, China
Beijing Tongren Hospital
RECRUITING

Beijing, China
Peking Union Medical College Hospital
RECRUITING

Beijing, China
TEDA International Cardiovascular Hospital
RECRUITING

Tianjin, China
The First People's Hospital of Foshan
RECRUITING

Foshan, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.